1-3 of 3
Nathalie Guillen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Subtractive Interaction Proteomics Reveal a Network of Signaling Pathways Activated By an Oncogenic Transcription Factor in High Risk AML

Claudia Chiriches, PhD, Nathalie Guillen, PhD, Michal Rokicki, Carol Guy, Afsar Mian, PhD, Oliver G. Ottmann, MD, Martin Ruthardt
Journal: Blood
Blood (2018) 132 (Supplement 1): 3917.
https://doi.org/10.1182/blood-2018-99-116631
Published: 2018
Journal Articles

A Network of Activated Cancer Signaling Pathways in a High Risk Subgroup of Acute Myeloid Leukemia Targetable By SRC-Kinase Inhibitors

Claudia Chiriches, PhD, Dilawar Khan, PhD, Nathalie Guillen, PhD, Michal Rokicki, Carol Guy, Afsar Mian, PhD, Oliver G. Ottmann, MD, Martin Ruthardt, MD
Journal: Blood
Blood (2016) 128 (22): 2746.
https://doi.org/10.1182/blood.V128.22.2746.2746
Published: 2016
Journal Articles

The GSK3β-Phosphorylation Sites in the DEK-Portion Are Indispensable for the Leukemogenic Potential of the DEK/CAN Fusion Protein in t(6;9)-Positive Acute Myeloid Leukemia

Claudia Oancea, PhD, Maria Heinßmann, Nathalie Guillen, Oliver G. Ottmann, MD, Martin Ruthardt, MD
Journal: Blood
Blood (2014) 124 (21): 3574.
https://doi.org/10.1182/blood.V124.21.3574.3574
Published: 2014